Hematopoietic Stem Cell Heterogeneity is Linked to the Initiation and Therapeutic Response of Myeloproliferative Neoplasms
Overview
Authors
Affiliations
Versatility of megakaryocytes in homeostasis and disease.
Wang D, Xie J, Zhao M Blood Sci. 2024; 6(4):e00212.
PMID: 39620204 PMC: 11608743. DOI: 10.1097/BS9.0000000000000212.
Myeloproliferative Neoplasms: Challenging Dogma.
Spivak J J Clin Med. 2024; 13(22).
PMID: 39598101 PMC: 11595126. DOI: 10.3390/jcm13226957.
Guo T, Pei F, Zhang M, Yamada T, Feng J, Jing J Cell Stem Cell. 2024; 31(6):904-920.e6.
PMID: 38703771 PMC: 11162319. DOI: 10.1016/j.stem.2024.04.011.
Depleting myeloid-biased haematopoietic stem cells rejuvenates aged immunity.
Ross J, Myers L, Noh J, Collins M, Carmody A, Messer R Nature. 2024; 628(8006):162-170.
PMID: 38538791 PMC: 11870232. DOI: 10.1038/s41586-024-07238-x.
Maslah N, Benajiba L, Giraudier S, Kiladjian J, Cassinat B Leukemia. 2023; 37(5):957-963.
PMID: 37002477 PMC: 10169637. DOI: 10.1038/s41375-023-01886-0.